Arkolith/Insider Trading/CASI/Form 4

Huang James

DirectorCASI Pharmaceuticals, Inc. (CASI) · full profile →Form 4 · filed Sep 8, 2022
Net Buying
Open-Market Buys
$230K
Open-Market Sells
$0
Net Open-Market Flow
$230K
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 8, 2022Buy(P)33K$4.28$143K372K
Sep 7, 2022Buy(P)3K$4.00$12K338K
Sep 6, 2022Buy(P)19K$3.89$75K335K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000899243-22-030690) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML